Eva Schaake

429 total citations
15 papers, 276 citations indexed

About

Eva Schaake is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Eva Schaake has authored 15 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Surgery. Recurrent topics in Eva Schaake's work include Advanced Radiotherapy Techniques (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Eva Schaake is often cited by papers focused on Advanced Radiotherapy Techniques (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Eva Schaake collaborates with scholars based in Netherlands, United Kingdom and Australia. Eva Schaake's co-authors include J. Belderbos, Jan‐Jakob Sonke, P. Remeijer, Margriet Kwint, J. Knegjens, Maddalena Rossi, Hendrik Koffijberg, J.A. Burgers, Bas A.J.M. de Mol and Karel G.M. Moons and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Physics in Medicine and Biology.

In The Last Decade

Eva Schaake

14 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Schaake Netherlands 6 207 117 105 49 34 15 276
Nasiruddin Mohammed United States 7 229 1.1× 129 1.1× 104 1.0× 47 1.0× 45 1.3× 15 303
Monica Lo Russo Italy 10 127 0.6× 105 0.9× 92 0.9× 61 1.2× 45 1.3× 24 276
Rebecca Levin-Epstein United States 8 225 1.1× 142 1.2× 88 0.8× 26 0.5× 37 1.1× 18 324
J. López Torrecilla Spain 9 139 0.7× 109 0.9× 97 0.9× 22 0.4× 35 1.0× 38 240
Matt Wronski Canada 10 164 0.8× 171 1.5× 136 1.3× 32 0.7× 31 0.9× 33 325
G. Siepe Italy 9 215 1.0× 89 0.8× 102 1.0× 34 0.7× 82 2.4× 32 310
Curtis Bryant United States 9 241 1.2× 141 1.2× 56 0.5× 98 2.0× 53 1.6× 30 341
Marketa Skala Australia 13 278 1.3× 158 1.4× 96 0.9× 62 1.3× 54 1.6× 23 392
Harijati Versmessen Belgium 7 241 1.2× 200 1.7× 108 1.0× 52 1.1× 48 1.4× 11 327
Thomas Yung United States 13 334 1.6× 190 1.6× 46 0.4× 55 1.1× 24 0.7× 43 384

Countries citing papers authored by Eva Schaake

Since Specialization
Citations

This map shows the geographic impact of Eva Schaake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Schaake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Schaake more than expected).

Fields of papers citing papers by Eva Schaake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Schaake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Schaake. The network helps show where Eva Schaake may publish in the future.

Co-authorship network of co-authors of Eva Schaake

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Schaake. A scholar is included among the top collaborators of Eva Schaake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Schaake. Eva Schaake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Jonker, Stephan A., Eva Schaake, Karel A. Hinnen, et al.. (2025). Omission of Contralateral Systematic Biopsies in Unilateral Suspicious Prostate Cancer on Magnetic Resonance Imaging: Implications for Radiation Treatment Selection. European Urology Open Science. 73. 17–23.
2.
Keek, Simon, A. Mans, Marlies E. Nowee, et al.. (2024). 865: Clinical evaluation of organs at risk deep learning auto-segmentation for cervix brachytherapy. Radiotherapy and Oncology. 194. S333–S336. 1 indexed citations
3.
Vries, Hielke M. de, Alberto Gil-Jimenez, Jeantine M. de Feijter, et al.. (2023). Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial. Journal of Clinical Oncology. 41(31). 4872–4880. 34 indexed citations
4.
Franckena, Martine, Joost L. Boormans, Jeantine M. de Feijter, et al.. (2022). A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice. European Urology Open Science. 39. 7–13. 4 indexed citations
5.
Schaake, Eva, et al.. (2022). External validation of nomograms for salvage radiotherapy after radical prostatectomy. British Journal of Urology. 129(5). 587–590. 1 indexed citations
6.
Nooij, Linda S., Eva Schaake, Anna K.L. Reyners, Henry Zijlmans, & Frédéric Amant. (2022). Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer. Current Opinion in Oncology. 34(5). 466–472. 2 indexed citations
7.
Schaake, Eva, et al.. (2021). Deformation trajectory prediction using a neural network trained on finite element data—application to library of CTVs creation for cervical cancer. Physics in Medicine and Biology. 66(21). 215004–215004. 5 indexed citations
8.
Nowee, Marlies E., Iris Walraven, Doenja M. J. Lambregts, et al.. (2021). The impact of image acquisition time on registration, delineation and image quality for magnetic resonance guided radiotherapy of prostate cancer patients. Physics and Imaging in Radiation Oncology. 19. 85–89. 4 indexed citations
10.
Walraven, Iris, Michel M. van den Heuvel, Judi van Diessen, et al.. (2016). Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab. Radiotherapy and Oncology. 118(3). 442–446. 54 indexed citations
11.
Kwint, Margriet, Eva Schaake, J. Knegjens, et al.. (2014). Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy. Radiotherapy and Oncology. 113(3). 392–397. 102 indexed citations
12.
Schaake, Eva, et al.. (2011). Markers for the non-invasive diagnosis of mesothelioma: a systematic review. British Journal of Cancer. 104(8). 1325–1333. 51 indexed citations
13.
Zandwijk, Nico van, Tjeerd S. Aukema, J. Belderbos, et al.. (2011). Cetuximab in combination with single agent daily cisplatin chemotherapy concurrent with radiotherapy in locally advanced nonsmall cell lung carcinoma: A feasibility study. 3 indexed citations
14.
Hilhorst, Riet, Eva Schaake, Renée van Pel, et al.. (2011). Blind prediction of response to erlotinib in early-stage non-small cell lung cancer (NSCLC) in a neoadjuvant setting based on kinase activity profiles.. Journal of Clinical Oncology. 29(15_suppl). 10521–10521. 3 indexed citations
15.
Hilhorst, Riet, Eva Schaake, Renée van Pel, et al.. (2010). Application of kinase activity profiles to predict response to erlotinib in a neoadjuvant setting in early stage non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 28(15_suppl). 10566–10566. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026